The Traderszone Network

Published in TZ Latest News 28 July, 2015 by The TZ Newswire Staff

Gilead posts huge beat on earnings and revenue

Gilead blew past analyst expectations on the top and bottom line, on the strength of strong sales for its hepatitis C treatments.